ERBB2 and breast cancer: Therefore, we investigated potential PEDF regulation of pro-metastatic biomarkers in ER+/HER2- BC and TNBC cells in the presence of physiologically relevant circulating oestrogen concentrations, as reported in pre- and post-menopausal BC patients [35].